These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
139 related articles for article (PubMed ID: 3349433)
1. Dormant dangers of DES. Nevin MM Can Nurse; 1988 Mar; 84(3):17-9. PubMed ID: 3349433 [No Abstract] [Full Text] [Related]
2. Diethylstilbestrol in pregnancy: an update. Kinch RA Can Med Assoc J; 1982 Nov; 127(9):812-3. PubMed ID: 7139494 [TBL] [Abstract][Full Text] [Related]
3. Structural changes of the genital tract associated with in utero exposure to diethylstilbestrol. Kaufman RH Obstet Gynecol Annu; 1982; 11():187-202. PubMed ID: 7110645 [TBL] [Abstract][Full Text] [Related]
4. Diethylstilbestrol (DES) Pregnancy Treatment: A Promising Widely Used Therapy with Unintended Adverse Consequences. Herbst AL; Anderson D AMA J Ethics; 2015 Sep; 17(9):865-70. PubMed ID: 26390210 [No Abstract] [Full Text] [Related]
5. [Fertility disorders attributable to the use of diethylstilbestrol during intrauterine life]. Drapier E Rev Fr Gynecol Obstet; 1984 Apr; 79(4):297-300, 303-5. PubMed ID: 6397835 [TBL] [Abstract][Full Text] [Related]
6. Past use of oestrogens during pregnancy in New Zealand. Paul C; Skegg DC; Seddon RJ N Z Med J; 1984 Nov; 97(768):831. PubMed ID: 6594627 [No Abstract] [Full Text] [Related]
7. Diethylstilbestrol exposure in utero: review of literature. Glaze GM J Am Osteopath Assoc; 1984 Feb; 83(6):435-8. PubMed ID: 6368486 [TBL] [Abstract][Full Text] [Related]
8. Adverse pregnancy outcome: sensitive periods, types of adverse outcomes, and relationships with critical exposure periods. Kochenour NK Prog Clin Biol Res; 1984; 160():229-35. PubMed ID: 6382329 [TBL] [Abstract][Full Text] [Related]
10. Pregnancy outcome in 98 women exposed to diethylstilbestrol in utero, their mothers, and unexposed siblings. Mangan CE; Borow L; Burtnett-Rubin MM; Egan V; Giuntoli RL; Mikuta JJ Obstet Gynecol; 1982 Mar; 59(3):315-9. PubMed ID: 7078877 [TBL] [Abstract][Full Text] [Related]
11. Urinary tract evaluation of diethylstilbestrol-exposed female progeny followed in a colposcopy clinic. Gallup DG; Altaffer LF; Castle CA J Reprod Med; 1984 Oct; 29(10):717-21. PubMed ID: 6512780 [TBL] [Abstract][Full Text] [Related]
12. DES: a living legacy what can nurses do about it? Lehmann A Can Nurse; 1983 Dec; 79(11):34-9. PubMed ID: 6556946 [No Abstract] [Full Text] [Related]
14. By the way, doctor. My mother took DES when she was pregnant with me. I'm now 69, my daughter is 41, and we've both had gynecological problems. What particular risks do we have because of our DES exposure, and what can we do about them? Richardson MK Harv Womens Health Watch; 2010 May; 17(9):7. PubMed ID: 20593559 [No Abstract] [Full Text] [Related]
15. Role of metabolic activation in the transplacental carcinogenicity of diethylstilbestrol. Metzler M Int J Biol Res Pregnancy; 1982; 3(3):103-7. PubMed ID: 7174140 [TBL] [Abstract][Full Text] [Related]
16. Behavior of estrogen-associated female genital tract cancer and its relation to neoplasia following intrauterine exposure to diethylstilbestrol (DES). Herbst AL Gynecol Oncol; 2000 Feb; 76(2):147-56. PubMed ID: 10637063 [No Abstract] [Full Text] [Related]
17. Perinatal toxicity of cocaine. Med Lett Drugs Ther; 1988 Jun; 30(767):59-60. PubMed ID: 3367855 [No Abstract] [Full Text] [Related]
18. Long-term effects on the female mouse genital tract associated with prenatal exposure to diethylstilbestrol. McLachlan JA; Newbold RR; Bullock BC Cancer Res; 1980 Nov; 40(11):3988-99. PubMed ID: 7193511 [No Abstract] [Full Text] [Related]